{"id":485,"date":"2026-02-28T10:10:01","date_gmt":"2026-02-28T10:10:01","guid":{"rendered":"https:\/\/heartcareforyou.in\/blog\/infective-endocarditis-definition-clinical-context-and-cardiology-overview\/"},"modified":"2026-02-28T10:10:01","modified_gmt":"2026-02-28T10:10:01","slug":"infective-endocarditis-definition-clinical-context-and-cardiology-overview","status":"publish","type":"post","link":"https:\/\/heartcareforyou.in\/blog\/infective-endocarditis-definition-clinical-context-and-cardiology-overview\/","title":{"rendered":"Infective Endocarditis: Definition, Clinical Context, and Cardiology Overview"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">Infective Endocarditis Introduction (What it is)<\/h2>\n\n\n\n<p>Infective Endocarditis is an infection of the heart\u2019s inner lining (the endocardium), most often involving a heart valve.<br\/>\nIt is a cardiovascular condition that combines microbiology, hemodynamics, and structural heart disease.<br\/>\nIt is commonly encountered in cardiology when evaluating fever with a heart murmur, stroke from emboli, or new\/worsening valve dysfunction.<br\/>\nIt is a high-stakes diagnosis because it can damage valves and spread infection to other organs.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Why Infective Endocarditis matters in cardiology (Clinical relevance)<\/h2>\n\n\n\n<p>Infective Endocarditis matters because it can rapidly change cardiac structure and function. A small infection on a valve can progress to severe valve regurgitation (leakage), heart failure, conduction abnormalities, or systemic emboli (infected material traveling to the brain, lungs, or other organs). These outcomes influence both short-term stability (for example, pulmonary edema from acute mitral regurgitation) and longer-term morbidity (for example, residual valve damage requiring repair or replacement).<\/p>\n\n\n\n<p>From an educational standpoint, Infective Endocarditis is a core example of clinical reasoning in cardiology: symptoms can be nonspecific, physical findings may be subtle, and diagnosis depends on integrating history, examination, microbiology, and imaging. Cardiology trainees learn how to interpret murmurs in context, when to pursue transthoracic echocardiography (TTE) versus transesophageal echocardiography (TEE), and how to think about complications such as periannular abscess.<\/p>\n\n\n\n<p>It is also a condition where risk stratification and treatment planning matter. Decisions commonly involve timing (how urgently to treat and whether to operate), team-based care (cardiology, infectious diseases, cardiac surgery, neurology), and balancing competing risks such as embolic stroke versus surgical timing. Protocols vary by institution, organism, and patient factors.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Classification \/ types \/ variants<\/h2>\n\n\n\n<p>Infective Endocarditis is commonly categorized along several clinically useful axes. These categories help frame likely pathogens, complications, imaging strategy, and management approach.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>By valve\/device involved<\/strong><\/li>\n<li><strong>Native valve Infective Endocarditis (NVE):<\/strong> infection on a patient\u2019s own valve.<\/li>\n<li><strong>Prosthetic valve Infective Endocarditis (PVE):<\/strong> infection involving a bioprosthetic or mechanical valve; may behave differently than NVE.<\/li>\n<li>\n<p><strong>Cardiac implantable electronic device (CIED) infection with endocarditis:<\/strong> infection involving pacemaker\/defibrillator leads, sometimes extending to valves.<\/p>\n<\/li>\n<li>\n<p><strong>By location<\/strong><\/p>\n<\/li>\n<li><strong>Left-sided Infective Endocarditis:<\/strong> typically mitral and\/or aortic valves; often associated with systemic emboli.<\/li>\n<li>\n<p><strong>Right-sided Infective Endocarditis:<\/strong> typically tricuspid valve; classically associated with septic pulmonary emboli.<\/p>\n<\/li>\n<li>\n<p><strong>By clinical tempo<\/strong><\/p>\n<\/li>\n<li><strong>Acute:<\/strong> faster onset, often with more severe systemic illness and rapid valve destruction.<\/li>\n<li>\n<p><strong>Subacute:<\/strong> more indolent course; symptoms may smolder and mimic other conditions.<\/p>\n<\/li>\n<li>\n<p><strong>By microbiologic data<\/strong><\/p>\n<\/li>\n<li><strong>Culture-positive:<\/strong> organism identified on blood cultures or other specimens.<\/li>\n<li>\n<p><strong>Culture-negative:<\/strong> no organism isolated, which can occur after prior antibiotics or with fastidious organisms; evaluation strategies vary by protocol.<\/p>\n<\/li>\n<li>\n<p><strong>By setting<\/strong><\/p>\n<\/li>\n<li><strong>Community-associated<\/strong> versus <strong>health care\u2013associated<\/strong> (including dialysis or recent hospitalization), which can shift pathogen likelihood and resistance patterns.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Relevant anatomy &amp; physiology<\/h2>\n\n\n\n<p>Understanding Infective Endocarditis starts with valve anatomy and blood flow. The endocardium lines the chambers and valves, and valves are exposed to high-velocity flow and pressure gradients. The <strong>mitral<\/strong> and <strong>aortic<\/strong> valves (left-sided) handle higher pressures and are frequently involved; the <strong>tricuspid<\/strong> valve (right-sided) can be involved, particularly when organisms enter venous circulation.<\/p>\n\n\n\n<p>Key anatomic and physiologic concepts include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Valve leaflets and supporting structures<\/strong><\/li>\n<li>The mitral valve includes leaflets, chordae tendineae, and papillary muscles; infection can damage any of these, leading to acute regurgitation.<\/li>\n<li>\n<p>The aortic valve sits near the conduction system and aortic root; infection can extend beyond the valve.<\/p>\n<\/li>\n<li>\n<p><strong>Perivalvular (periannular) tissue<\/strong><\/p>\n<\/li>\n<li>\n<p>Infection can spread from leaflets into surrounding tissue, forming an <strong>abscess<\/strong> near the valve annulus. This is clinically important because it can destabilize the valve and affect conduction.<\/p>\n<\/li>\n<li>\n<p><strong>Hemodynamics and murmurs<\/strong><\/p>\n<\/li>\n<li>Vegetations (infected masses) may prevent leaflet coaptation, worsening regurgitation and changing murmurs.<\/li>\n<li>\n<p>Acute severe regurgitation can cause pulmonary edema or cardiogenic shock in some cases.<\/p>\n<\/li>\n<li>\n<p><strong>Conduction system<\/strong><\/p>\n<\/li>\n<li>\n<p>The atrioventricular (AV) node and His bundle lie near the aortic and mitral annuli. Extension of infection can produce PR prolongation, AV block, or new bundle branch block, depending on the site.<\/p>\n<\/li>\n<li>\n<p><strong>Embolic pathways<\/strong><\/p>\n<\/li>\n<li>Left-sided vegetations can embolize to systemic organs (brain, spleen, kidneys).<\/li>\n<li>Right-sided vegetations can embolize to the pulmonary circulation, causing septic pulmonary emboli.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Pathophysiology or mechanism<\/h2>\n\n\n\n<p>Infective Endocarditis generally requires two ingredients: a bloodstream pathogen and a surface where it can adhere and persist. While details vary by organism and patient factors, the core mechanism is often described in steps:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>\n<p><strong>Endothelial injury or abnormal flow<\/strong>\n   &#8211; Turbulent jets across abnormal valves, prosthetic material, or congenital lesions can injure endocardium. This may promote deposition of platelets and fibrin, forming a small sterile nidus sometimes termed nonbacterial thrombotic endocarditis (a descriptive concept rather than a single diagnosis in this context).<\/p>\n<\/li>\n<li>\n<p><strong>Bacteremia (or fungemia)<\/strong>\n   &#8211; Microorganisms enter the bloodstream from skin, oral sources, intravascular catheters, injections, or other infection sites. The likelihood and organism type depend on exposure and comorbidities, and varies by clinician and case.<\/p>\n<\/li>\n<li>\n<p><strong>Adherence and vegetation formation<\/strong>\n   &#8211; Certain organisms (for example, some staphylococci and streptococci) possess adherence factors that help them bind to damaged endothelium or prosthetic material. They multiply within a matrix of fibrin and platelets, forming a <strong>vegetation<\/strong>.<\/p>\n<\/li>\n<li>\n<p><strong>Local destruction and systemic effects<\/strong>\n   &#8211; Vegetations can mechanically disrupt valve function, leading to regurgitation and heart failure.\n   &#8211; Infection may invade adjacent tissue, causing abscess, fistula, or prosthetic valve dehiscence.\n   &#8211; Pieces of vegetation can break off (embolize), causing infarcts, abscesses, or metastatic infection.\n   &#8211; Immune-mediated phenomena can occur, such as glomerulonephritis, reflecting circulating immune complexes in some cases.<\/p>\n<\/li>\n<\/ol>\n\n\n\n<h2 class=\"wp-block-heading\">Clinical presentation or indications<\/h2>\n\n\n\n<p>Infective Endocarditis can present in classic or subtle ways. Typical clinical scenarios include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Fever<\/strong> with a new murmur or a change in a known murmur<\/li>\n<li><strong>Constitutional symptoms<\/strong> such as fatigue, malaise, night sweats, or weight loss (more common in subacute presentations)<\/li>\n<li><strong>Acute heart failure symptoms<\/strong> (dyspnea, orthopnea) due to sudden severe valve regurgitation<\/li>\n<li><strong>Embolic events<\/strong><\/li>\n<li>Stroke-like symptoms, confusion, focal neurologic deficits<\/li>\n<li>Abdominal pain from splenic or renal infarcts<\/li>\n<li>Limb ischemia or painful digits (less common but clinically important)<\/li>\n<li><strong>Right-sided features<\/strong> (often tricuspid involvement)<\/li>\n<li>Pleuritic chest pain, cough, hemoptysis, or shortness of breath from septic pulmonary emboli<\/li>\n<li><strong>Persistent bacteremia<\/strong> noted on repeated blood cultures<\/li>\n<li><strong>Signs of metastatic infection<\/strong> such as vertebral osteomyelitis\u2013type back pain, or focal organ abscess symptoms (varies by patient and organism)<\/li>\n<\/ul>\n\n\n\n<p>Physical exam findings can include murmurs and stigmata of endocarditis (for example, petechiae or splinter hemorrhages), though these are not present in all patients and should be interpreted in context.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Diagnostic evaluation &amp; interpretation<\/h2>\n\n\n\n<p>Diagnosis relies on combining microbiology, imaging, and clinical findings. A widely taught framework is the <strong>modified Duke criteria<\/strong>, which organizes evidence into major and minor criteria. Clinicians use this framework to support diagnostic certainty, but real-world decisions also incorporate illness severity and complications.<\/p>\n\n\n\n<p>Common elements of the evaluation include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>History and risk assessment<\/strong><\/li>\n<li>\n<p>Prior valve disease, prosthetic valves, congenital heart disease, hemodialysis, intravascular devices, prior endocarditis, injection exposures, recent bacteremia, and recent procedures that could seed the bloodstream (risk varies by patient factors).<\/p>\n<\/li>\n<li>\n<p><strong>Physical examination<\/strong><\/p>\n<\/li>\n<li>\n<p>Murmur characterization, signs of heart failure, vascular\/embolic signs, and neurologic assessment.<\/p>\n<\/li>\n<li>\n<p><strong>Blood cultures (microbiology cornerstone)<\/strong><\/p>\n<\/li>\n<li>Multiple blood cultures obtained before antibiotics when feasible are central for identifying the organism and tailoring therapy.<\/li>\n<li>Persistent positivity can support the diagnosis and suggest uncontrolled infection or a deep focus.<\/li>\n<li>\n<p>If cultures are negative, clinicians consider prior antibiotics and fastidious organisms; additional serologic or molecular testing varies by protocol and setting.<\/p>\n<\/li>\n<li>\n<p><strong>Laboratory tests<\/strong><\/p>\n<\/li>\n<li>Inflammatory markers and complete blood count can support systemic infection but are nonspecific.<\/li>\n<li>Urinalysis may show hematuria or proteinuria in immune-mediated involvement.<\/li>\n<li>\n<p>Renal and hepatic function help guide supportive care and antimicrobial safety monitoring.<\/p>\n<\/li>\n<li>\n<p><strong>Echocardiography (structural assessment)<\/strong><\/p>\n<\/li>\n<li><strong>Transthoracic echocardiography (TTE):<\/strong> noninvasive first-line imaging in many cases to look for vegetations, regurgitation, and ventricular function.<\/li>\n<li><strong>Transesophageal echocardiography (TEE):<\/strong> higher sensitivity for vegetations, prosthetic valves, and periannular complications; often used when suspicion is high or TTE is nondiagnostic.<\/li>\n<li>\n<p>Findings clinicians look for include mobile masses consistent with vegetations, valve perforation, new regurgitation, abscess, and prosthetic valve complications.<\/p>\n<\/li>\n<li>\n<p><strong>Electrocardiogram (ECG)<\/strong><\/p>\n<\/li>\n<li>\n<p>Useful for new conduction abnormalities that may suggest extension near the conduction system (for example, new AV block), although ECG changes are not specific.<\/p>\n<\/li>\n<li>\n<p><strong>Additional imaging (case-dependent)<\/strong><\/p>\n<\/li>\n<li>Brain imaging for neurologic symptoms, computed tomography (CT) or magnetic resonance imaging (MRI) for embolic complications, and nuclear imaging in selected prosthetic valve or device cases (use varies by protocol and availability).<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Management overview (General approach)<\/h2>\n\n\n\n<p>Management typically combines antimicrobial therapy, complication surveillance, and\u2014when indicated\u2014procedural or surgical intervention. Specific regimens, duration, and timing vary by organism, valve type, drug sensitivities, and patient factors.<\/p>\n\n\n\n<p>Key principles include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Early multidisciplinary care<\/strong><\/li>\n<li>\n<p>Many centers use an \u201cendocarditis team\u201d model involving cardiology, infectious diseases, cardiac surgery, and other specialties such as neurology.<\/p>\n<\/li>\n<li>\n<p><strong>Antimicrobial therapy<\/strong><\/p>\n<\/li>\n<li>Treatment often begins with empiric antibiotics after appropriate cultures, then narrows to targeted therapy once organism and susceptibilities are known.<\/li>\n<li>Therapy is commonly given intravenously, reflecting the need for sustained bactericidal levels in vegetations.<\/li>\n<li>\n<p>Monitoring for drug toxicity and response (clinical status, repeat cultures, lab trends) is part of standard care.<\/p>\n<\/li>\n<li>\n<p><strong>Source control and device management<\/strong><\/p>\n<\/li>\n<li>\n<p>If a catheter, pacemaker\/defibrillator lead, or other device is implicated, management may involve removal and replacement planning, depending on stability and infection extent (approach varies by protocol and patient factors).<\/p>\n<\/li>\n<li>\n<p><strong>Management of hemodynamic consequences<\/strong><\/p>\n<\/li>\n<li>\n<p>Heart failure due to severe regurgitation may require diuretics, afterload management, and escalation of care; choices depend on clinical status and comorbidities.<\/p>\n<\/li>\n<li>\n<p><strong>Surgical or interventional management (selected cases)<\/strong><\/p>\n<\/li>\n<li>Surgery may be considered for:<ul>\n<li>Severe valve dysfunction causing heart failure<\/li>\n<li>Uncontrolled infection (for example, abscess, persistent bacteremia)<\/li>\n<li>Prevention of embolic events in patients with high-risk vegetations (criteria vary by guideline and case)<\/li>\n<li>Prosthetic valve complications (dehiscence, paravalvular leak, abscess)<\/li>\n<\/ul>\n<\/li>\n<li>\n<p>The decision balances operative risk, neurologic events, organism factors, and anatomy; timing is individualized.<\/p>\n<\/li>\n<li>\n<p><strong>Secondary prevention (context-dependent)<\/strong><\/p>\n<\/li>\n<li>For some high-risk cardiac conditions, clinicians may discuss antibiotic prophylaxis before certain procedures; recommendations vary by guideline, procedure type, and patient risk profile.<\/li>\n<\/ul>\n\n\n\n<p>This overview is educational; treatment decisions are individualized and clinician-directed.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Complications, risks, or limitations<\/h2>\n\n\n\n<p>Infective Endocarditis can affect multiple organ systems. Common complications and important limitations in care include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Cardiac complications<\/strong><\/li>\n<li>Acute or progressive <strong>valve regurgitation<\/strong> leading to <strong>heart failure<\/strong><\/li>\n<li><strong>Periannular abscess<\/strong>, fistula formation, or pseudoaneurysm (especially around the aortic valve)<\/li>\n<li><strong>Conduction abnormalities<\/strong> (PR prolongation, AV block) from extension near conduction tissue<\/li>\n<li><strong>Prosthetic valve dehiscence<\/strong> or paravalvular leak<\/li>\n<li>\n<p>Less commonly, <strong>pericardial involvement<\/strong> depending on spread<\/p>\n<\/li>\n<li>\n<p><strong>Embolic and neurologic complications<\/strong><\/p>\n<\/li>\n<li>Ischemic stroke or transient neurologic deficits from emboli<\/li>\n<li>Intracranial hemorrhage can occur in some contexts (risk varies by lesion type and therapies)<\/li>\n<li>\n<p>Mycotic (infectious) aneurysms can develop in cerebral or systemic arteries (recognized variably)<\/p>\n<\/li>\n<li>\n<p><strong>Pulmonary complications (more typical in right-sided disease)<\/strong><\/p>\n<\/li>\n<li>\n<p>Septic pulmonary emboli, pulmonary infarcts, pleural effusions<\/p>\n<\/li>\n<li>\n<p><strong>Renal complications<\/strong><\/p>\n<\/li>\n<li>Infarction from emboli<\/li>\n<li>\n<p>Immune-complex glomerulonephritis, which can affect kidney function<\/p>\n<\/li>\n<li>\n<p><strong>Systemic infection complications<\/strong><\/p>\n<\/li>\n<li>Metastatic abscesses (spleen, spine, joints) depending on organism and duration<\/li>\n<li>\n<p>Sepsis and septic shock in severe cases<\/p>\n<\/li>\n<li>\n<p><strong>Diagnostic limitations<\/strong><\/p>\n<\/li>\n<li>Blood cultures may be negative after prior antibiotic exposure.<\/li>\n<li>Echocardiography can miss small vegetations or early disease; TEE is more sensitive but still not perfect.<\/li>\n<li>Some findings overlap with noninfectious mimics, so clinicians interpret results in clinical context.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Prognosis &amp; follow-up considerations<\/h2>\n\n\n\n<p>Prognosis in Infective Endocarditis depends on multiple factors rather than a single finding. Important influences include the affected valve (native versus prosthetic), left-sided versus right-sided location, the organism and its antimicrobial susceptibility, the presence of complications (heart failure, stroke, abscess), and the patient\u2019s baseline health (renal disease, immunosuppression, frailty).<\/p>\n\n\n\n<p>Many patients improve with timely diagnosis and appropriate therapy, but recovery can be prolonged because the condition involves both infection control and potential structural heart damage. Some individuals require valve surgery during the index hospitalization, while others may need surveillance for progressive regurgitation or late complications.<\/p>\n\n\n\n<p>Follow-up commonly focuses on:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Clinical recovery<\/strong><\/li>\n<li>\n<p>Resolution of fever and systemic symptoms, improvement in functional status, and monitoring for relapse symptoms.<\/p>\n<\/li>\n<li>\n<p><strong>Microbiologic cure<\/strong><\/p>\n<\/li>\n<li>\n<p>Documenting clearance of bacteremia during treatment is often important; strategies vary by protocol.<\/p>\n<\/li>\n<li>\n<p><strong>Structural assessment<\/strong><\/p>\n<\/li>\n<li>\n<p>Repeat echocardiography may be used to reassess valve function, ventricular performance, and resolution or progression of vegetations or abscesses (timing varies by clinician and case).<\/p>\n<\/li>\n<li>\n<p><strong>Rehabilitation and risk factor modification<\/strong><\/p>\n<\/li>\n<li>Return to work, exercise, and procedural planning is individualized based on cardiac function, neurologic complications, and surgery status.<\/li>\n<\/ul>\n\n\n\n<p>This section describes general considerations and does not substitute for clinician-directed follow-up planning.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Infective Endocarditis Common questions (FAQ)<\/h2>\n\n\n\n<p><strong>Q: What does Infective Endocarditis mean in plain language?<\/strong><br\/>\nIt means an infection has attached to the inner surface of the heart, most often a heart valve. The infection forms a mass of germs and clot-like material called a vegetation. This can damage the valve and sometimes send infected particles to other organs.<\/p>\n\n\n\n<p><strong>Q: Is Infective Endocarditis the same as a heart murmur?<\/strong><br\/>\nNo. A murmur is a sound from turbulent blood flow and can have many causes. Infective Endocarditis can cause a new murmur or change an existing one by damaging a valve, but a murmur alone does not diagnose infection.<\/p>\n\n\n\n<p><strong>Q: How do clinicians usually confirm Infective Endocarditis?<\/strong><br\/>\nConfirmation typically relies on blood cultures to identify the organism and echocardiography to evaluate valves for vegetations or complications. Clinicians often use the modified Duke criteria to combine microbiology, imaging, and clinical features. The exact pathway can vary by protocol and patient stability.<\/p>\n\n\n\n<p><strong>Q: Why are blood cultures so important?<\/strong><br\/>\nBlood cultures can show which organism is in the bloodstream and guide targeted antibiotic selection. They also help clinicians assess whether bacteremia is clearing with treatment. Prior antibiotics can reduce culture yield, which is one reason timing and technique matter.<\/p>\n\n\n\n<p><strong>Q: What is the difference between TTE and TEE for Infective Endocarditis?<\/strong><br\/>\nTransthoracic echocardiography (TTE) is an ultrasound done on the chest wall and is often the first test because it is noninvasive. Transesophageal echocardiography (TEE) places the probe in the esophagus, closer to the heart, and generally detects smaller vegetations and prosthetic valve complications more reliably. Which test is used depends on suspicion level, valve type, and image quality.<\/p>\n\n\n\n<p><strong>Q: Can Infective Endocarditis cause a stroke?<\/strong><br\/>\nYes. Vegetations can shed emboli that travel to the brain and block an artery, causing an ischemic stroke. Some patients also develop other neurologic complications, and risk varies by vegetation features, organism, and clinical course.<\/p>\n\n\n\n<p><strong>Q: Does everyone with Infective Endocarditis need heart surgery?<\/strong><br\/>\nNo. Many patients are managed with antimicrobial therapy alone, especially when valve function remains stable and complications are absent. Surgery may be considered when there is severe valve dysfunction, uncontrolled infection, abscess, or high-risk embolic potential, but decisions vary by clinician and case.<\/p>\n\n\n\n<p><strong>Q: How long does recovery usually take?<\/strong><br\/>\nRecovery time varies by patient factors, organism, complications, and whether surgery was needed. Treatment often requires a prolonged course of antibiotics and follow-up to monitor valve function and overall health. Functional recovery may extend beyond the infection\u2019s clearance, especially after heart failure or neurologic events.<\/p>\n\n\n\n<p><strong>Q: When can someone return to exercise, school, or work after Infective Endocarditis?<\/strong><br\/>\nReturn to normal activity is individualized and depends on cardiac function, symptoms, and complications such as stroke or surgery. Clinicians often consider energy level, hemodynamic stability, and follow-up imaging findings. Plans vary by protocol and patient factors.<\/p>\n\n\n\n<p><strong>Q: Can Infective Endocarditis come back?<\/strong><br\/>\nRecurrence can happen, either as relapse (same organism not fully eradicated) or reinfection (a new episode). Risk depends on underlying valve disease, prosthetic material, ongoing exposure risks, and how effectively the initial infection source was controlled. Follow-up and preventive strategies are tailored to the individual context.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Infective Endocarditis is an infection of the heart\u2019s inner lining (the endocardium), most often involving a heart valve. It is a cardiovascular condition that combines microbiology, hemodynamics, and structural heart disease. It is commonly encountered in cardiology when evaluating fever with a heart murmur, stroke from emboli, or new\/worsening valve dysfunction. It is a high-stakes diagnosis because it can damage valves and spread infection to other organs.<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-485","post","type-post","status-publish","format-standard","hentry"],"_links":{"self":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/posts\/485","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/comments?post=485"}],"version-history":[{"count":0,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/posts\/485\/revisions"}],"wp:attachment":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/media?parent=485"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/categories?post=485"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/tags?post=485"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}